Global and regional AMR stakeholders
A number of organisations are working to address AMR globally, with a broad remit. Table 1 lists some key global stakeholders that focus (with the exception of the Tripartite) exclusively on AMR. This table is not an exhaustive list, and you should also be aware that many larger organisations (for example the Bill and Melinda Gates Foundation, or the Wellcome Trust) may also have significant AMR programmes within their overall scope of work.
Stakeholder | Sector | Strategic focus |
---|---|---|
Tripartite Collaboration (WHO, FAO, OIE) | Human health, animal health, environment | Policy |
ReAct | Human health, animal health | Advocacy |
Antibiotic Resistance Coalition (ARC) | Human health, animal health, environment, One Health | Advocacy |
World Alliance Against Antibiotic Resistance (WAAAR) | Human health, animal health, environment, One Health | Advocacy |
The AMR Industry Alliance | Human health, environment | Advocacy |
Global Antibiotic Research & Development Partnership (GARDP) | Human health | Innovation and research |
Community for Open Antimicrobial Drug Discovery (CO-ADD) | Human health | Innovation and research |
Global Antimicrobial Resistance Surveillance System (GLASS) | Human health, One Health in the near future | Surveillance |
Gonococcal Antimicrobial Surveillance Program (GASP) | Human health | Surveillance |
The Fleming Fund | Human health, animal health, One Health | Funding |
The Global AMR Innovation Fund (GAMRIF) | Human health, animal health, One Health | Funding |
AMR Action Fund | Human health, animal health, One Health | Funding |
Funding for surveillance is not always a priority of national governments, particularly in LMICs. In these cases, AMR stakeholders that work in the region can help to address AMR. Some international initiatives offer financial and technical support for building laboratory and surveillance capability in these countries; for example, initiatives supporting the surveillance elements of the Global Health Security Agenda, the Fleming Fund and the World Bank’s Regional Disease Surveillance Systems Enhancement programme, which supports countries in the Economic Community of West African States in strengthening national surveillance systems and intercountry collaboration.
Additional regional AMR stakeholders are listed by sector and strategic focus in Table 2.
Stakeholder | Sector | Strategic focus | Region |
---|---|---|---|
Asia-Pacific Economic Cooperation (APEC) | Human health | Policy | South-east Asia |
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) | Human health, animal health, environment, One Health | Innovation and research | Europe |
Asian Network for Surveillance of Resistant Pathogens (ANSORP) | Human health | Surveillance | South-east Asia |
Partnership for AMR Surveillance Excellence (PARSE) | Human health, animal health | Surveillance | Africa and Asia |
2.1 Identifying key stakeholders